TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial (Q40149008)
Jump to navigation
Jump to search
scientific article published on 22 December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial |
scientific article published on 22 December 2015 |
Statements
1 reference
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial (English)
1 reference
1 reference
Gyorgy Losonczy
1 reference
Aleksandra Szczesna
1 reference
Elisabeth Quoix
1 reference
Hervé Lena
1 reference
Frédéric Forget
1 reference
Zsolt Papai
1 reference
Radj Gervais
1 reference
Andrzej Kazarnowicz
1 reference
Joseph T Beck
1 reference
Virginie Westeel
1 reference
Didier Debieuvre
1 reference
Anne Madroszyk
1 reference
Julien Adam
1 reference
Gisèle Lacoste
1 reference
Annette Tavernaro
1 reference
Bérangère Bastien
1 reference
Céline Halluard
1 reference
Tania Palanché
1 reference
Jean-Marc Limacher
1 reference
22 December 2015
1 reference
1 reference
17
1 reference
2
1 reference
212-223
1 reference
Identifiers
1 reference
1 reference